| |
|
|
| Name: |
Frazier Life Sciences Management L.P. |
| City: |
Menlo Park |
| State: |
CA |
| Zip: |
94025 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
55 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
NAMS |
Newamsterdam Pharma Ord Shs |
1 |
- |
$0.00 |
$289,167,000 |
12,226,943 |
12.2% |
153,656,000 |
95,238 |
14.991 |
N/A |
|
|
KRYS |
Krystal Biotech Inc |
2 |
- |
$169.25 |
$175,877,000 |
988,460 |
7.42% |
53,249,000 |
0 |
3.968 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
3 |
- |
$0.00 |
$163,164,000 |
6,495,392 |
6.88% |
-28,580,000 |
0 |
12.118 |
N/A |
|
|
HLVX |
Hillevax, Inc. |
4 |
- |
$14.14 |
$162,666,000 |
9,781,472 |
6.86% |
5,673,000 |
0 |
20.193 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
5 |
- |
$64.97 |
$124,113,000 |
3,131,008 |
5.24% |
64,436,000 |
0 |
4.777 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
6 |
- |
$0.00 |
$107,361,000 |
10,109,279 |
4.53% |
15,063,000 |
0 |
17.658 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
7 |
- |
$29.27 |
$105,610,000 |
3,415,604 |
4.46% |
-4,437,000 |
689,655 |
1.963 |
N/A |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
8 |
- |
$37.84 |
$94,900,000 |
2,190,179 |
4% |
-14,109,000 |
-181,125 |
3.088 |
N/A |
|
|
ARQT |
Arcutis Biotherapeutics, Inc. |
9 |
- |
$9.92 |
$87,062,000 |
8,785,284 |
3.67% |
58,754,000 |
21,052 |
8.251 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
10 |
- |
$0.00 |
$77,833,000 |
1,139,405 |
3.28% |
4,708,000 |
-25,000 |
1.056 |
N/A |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
11 |
- |
$0.00 |
$64,977,000 |
1,787,527 |
2.74% |
28,780,000 |
0 |
5.399 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
12 |
- |
$0.00 |
$60,257,000 |
3,303,567 |
2.54% |
31,078,000 |
636,364 |
3.58 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
13 |
- |
$0.00 |
$56,964,000 |
4,142,855 |
2.4% |
37,250,000 |
2,000,000 |
6.179 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
14 |
- |
$43.60 |
$52,030,000 |
885,165 |
2.2% |
-956,000 |
0 |
0.773 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
15 |
- |
$33.17 |
$48,874,000 |
785,000 |
2.06% |
3,532,000 |
0 |
3.252 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
16 |
- |
$0.00 |
$48,501,000 |
3,014,349 |
2.05% |
-11,424,000 |
0 |
3.736 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
17 |
- |
$11.69 |
$43,738,000 |
3,687,867 |
1.85% |
-635,000 |
65,573 |
9.701 |
N/A |
|
|
RCKT |
Rocket Pharmaceuticals |
18 |
- |
$22.44 |
$42,060,000 |
1,561,230 |
1.77% |
-3,585,000 |
38,217 |
1.686 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
19 |
- |
$0.16 |
$37,479,000 |
875,667 |
1.58% |
18,765,000 |
410,730 |
1.1 |
N/A |
|
|
MGNX |
Macrogenics Inc |
20 |
- |
$4.70 |
$36,383,000 |
2,471,704 |
1.54% |
13,279,000 |
70,000 |
3.985 |
Biotechnology |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
21 |
- |
$0.00 |
$35,628,000 |
1,204,867 |
1.5% |
8,362,000 |
0 |
4.354 |
N/A |
|
|
CGON |
CG Oncology, Inc |
22 |
New |
$30.81 |
$33,803,000 |
770,000 |
1.43% |
33,803,000 |
770,000 |
1.167 |
N/A |
|
|
MRUS |
Merus Nv |
23 |
- |
$43.40 |
$33,614,000 |
746,479 |
1.42% |
13,086,000 |
0 |
1.293 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
24 |
- |
$39.77 |
$32,148,000 |
997,455 |
1.36% |
3,541,000 |
0 |
0.609 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
25 |
- |
$3.84 |
$29,497,000 |
4,623,324 |
1.24% |
5,367,000 |
876,467 |
2.672 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
26 |
- |
$36.38 |
$26,967,000 |
629,194 |
1.14% |
14,038,000 |
312,004 |
1.356 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
27 |
- |
$0.00 |
$25,465,000 |
7,381,090 |
1.07% |
15,574,000 |
0 |
12.318 |
N/A |
|
|
SLN |
Silence Therapeutics Adr Re... |
28 |
- |
$0.00 |
$24,810,000 |
1,148,591 |
1.05% |
9,504,000 |
267,418 |
3.853 |
N/A |
|
|
DCPH |
Deciphera Pharmaceuticals, ... |
29 |
- |
$25.48 |
$22,900,000 |
1,455,837 |
0.97% |
6,418,000 |
434,037 |
2.389 |
N/A |
|
|
PEPG |
Pepgen Inc. |
30 |
New |
$14.06 |
$22,091,000 |
1,502,788 |
0.93% |
22,091,000 |
1,502,788 |
6.36 |
N/A |
|
|
ANAB |
Anaptysbio Inc |
31 |
- |
$25.04 |
$20,261,000 |
899,700 |
0.85% |
989,000 |
0 |
2.829 |
N/A |
|
|
SVRA |
Savara Inc |
32 |
- |
$4.33 |
$19,920,000 |
4,000,000 |
0.84% |
1,120,000 |
0 |
2.956 |
Biotechnology |
|
|
CERE |
Cerevel Therapeutics Holdin... |
33 |
- |
$41.65 |
$16,612,000 |
393,000 |
0.7% |
-51,000 |
0 |
0.251 |
N/A |
|
|
AGIO |
Agios Pharmaceuticals Inc |
34 |
- |
$33.44 |
$15,297,000 |
523,166 |
0.65% |
3,646,000 |
0 |
0.757 |
N/A |
|
|
ADVM |
Adverum Biotechnologies, Inc |
35 |
New |
$7.90 |
$15,119,000 |
1,069,244 |
0.64% |
15,119,000 |
1,069,244 |
1.059 |
N/A |
|
|
PBYI |
Puma Biotechnology Inc |
36 |
New |
$4.23 |
$14,926,000 |
2,816,294 |
0.63% |
14,926,000 |
2,816,294 |
7.083 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
37 |
- |
$0.00 |
$13,648,000 |
832,220 |
0.58% |
-568,000 |
-194,200 |
2.017 |
N/A |
|
|
APLT |
Applied Therapeutics Inc. |
38 |
New |
$0.00 |
$13,279,000 |
1,952,857 |
0.56% |
13,279,000 |
1,952,857 |
2.529 |
N/A |
|
|
ALLO |
Allogene Therapeutics, Inc. |
39 |
New |
$0.00 |
$12,819,000 |
2,867,750 |
0.54% |
12,819,000 |
2,867,750 |
2.044 |
N/A |
|
|
ARVN |
Arvinas Holding Company, Llc |
40 |
- |
$35.95 |
$11,778,000 |
285,331 |
0.5% |
34,000 |
0 |
0.415 |
N/A |
|
|
ETNB |
89bio, Inc. |
41 |
- |
$8.93 |
$11,640,000 |
1,000,000 |
0.49% |
-10,700,000 |
-1,000,000 |
1.022 |
N/A |
|
|
ACAD |
Acadia Pharmaceuticals Inc |
42 |
- |
$15.82 |
$8,697,000 |
470,338 |
0.37% |
-14,188,000 |
-260,579 |
0.293 |
Biotechnology |
|
|
COGT |
Cogent Biosciences, Inc. |
43 |
- |
$8.03 |
$6,294,000 |
936,576 |
0.27% |
-5,438,000 |
-1,058,691 |
0.989 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
44 |
- |
$25.97 |
$5,603,000 |
203,684 |
0.24% |
-607,000 |
0 |
0.227 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
45 |
- |
$2.12 |
$4,514,000 |
1,388,889 |
0.19% |
-23,944,000 |
0 |
4.67 |
N/A |
|
|
MGX |
Metagenomi, Inc. |
46 |
New |
$7.17 |
$2,944,000 |
279,025 |
0.12% |
2,944,000 |
279,025 |
0.745 |
N/A |
|
|
GRTS |
Gritstone Oncology, Inc. |
47 |
- |
$0.84 |
$2,649,000 |
1,030,878 |
0.11% |
546,000 |
0 |
1.516 |
N/A |
|
|
BLUE |
Bluebird Bio, Inc. |
48 |
- |
$0.98 |
$2,189,000 |
1,709,907 |
0.09% |
-171,000 |
0 |
1.229 |
Biotechnology |
|
|
ACRS |
Aclaris Therapeutics, Inc. |
49 |
- |
$1.15 |
$328,000 |
264,377 |
0.01% |
50,000 |
0 |
0.357 |
N/A |
|
|
THRX |
Theseus Pharmaceuticals, Inc. |
54 |
Closed |
$0.00 |
$0 |
0 |
0% |
-8,578,000 |
-2,118,051 |
0 |
N/A |
|
|
MRTX |
Mirati Therapeutics, Inc. |
53 |
Closed |
$58.70 |
$0 |
0 |
0% |
-4,700,000 |
-80,000 |
0 |
Biotechnology |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
52 |
Closed |
$235.06 |
$0 |
0 |
0% |
-16,059,000 |
-69,406 |
0 |
Diagnostic Substances |
|
|
DYN |
Dyne Therapeutics, Inc. |
51 |
Closed |
$31.53 |
$0 |
0 |
0% |
-15,758,000 |
-1,184,840 |
0 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
50 |
Closed |
$50.54 |
$0 |
0 |
0% |
-14,142,000 |
-397,483 |
0 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
55 |
Closed |
$47.87 |
$0 |
0 |
0% |
-11,176,000 |
-400,000 |
0 |
N/A |
|
